
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Scinai Immunotherapeutics (NASDAQ:SCNI) through any online brokerage.
Other companies in Scinai Immunotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Scinai Immunotherapeutics to provide a consensus price target.
The stock price for Scinai Immunotherapeutics (NASDAQ: SCNI) is $1.215 last updated October 8, 2026 at 3:58 PM EDT.
There are no upcoming dividends for Scinai Immunotherapeutics.
Scinai Immunotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Scinai Immunotherapeutics.
Scinai Immunotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing...